181 related articles for article (PubMed ID: 18417407)
1. [Clearance, persistence and recurrence of HPV infection].
Denis F; Hanz S; Alain S
Gynecol Obstet Fertil; 2008 Apr; 36(4):430-40. PubMed ID: 18417407
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
Koutsky LA; Holmes KK; Critchlow CW; Stevens CE; Paavonen J; Beckmann AM; DeRouen TA; Galloway DA; Vernon D; Kiviat NB
N Engl J Med; 1992 Oct; 327(18):1272-8. PubMed ID: 1328880
[TBL] [Abstract][Full Text] [Related]
3. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong.
Chan PK; Mak KH; Cheung JL; Tang NL; Chan DP; Lo KK; Cheng AF
J Med Virol; 2002 Oct; 68(2):273-7. PubMed ID: 12210419
[TBL] [Abstract][Full Text] [Related]
4. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of human papillomavirus infections.
Baseman JG; Koutsky LA
J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
Cuschieri KS; Whitley MJ; Cubie HA
J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
[TBL] [Abstract][Full Text] [Related]
7. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.
Liaw KL; Hildesheim A; Burk RD; Gravitt P; Wacholder S; Manos MM; Scott DR; Sherman ME; Kurman RJ; Glass AG; Anderson SM; Schiffman M
J Infect Dis; 2001 Jan; 183(1):8-15. PubMed ID: 11087198
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
10. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study.
Louvanto K; Rintala MA; Syrjänen KJ; Grénman SE; Syrjänen SM
J Infect Dis; 2010 Aug; 202(3):436-44. PubMed ID: 20557239
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
[TBL] [Abstract][Full Text] [Related]
12. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
Castellsagué X; Muñoz N
J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy.
Broccolo F; Chiari S; Piana A; Castiglia P; Dell'Anna T; Garcia-Parra R; Maneo A; Villa A; Leone EB; Perego P; Maida A; Mangioni C; Cocuzza CE
J Med Virol; 2009 Feb; 81(2):278-87. PubMed ID: 19107971
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
15. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
[TBL] [Abstract][Full Text] [Related]
16. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
17. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
18. Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women.
Nielsen A; Kjaer SK; Munk C; Osler M; Iftner T
J Med Virol; 2010 Apr; 82(4):616-23. PubMed ID: 20166190
[TBL] [Abstract][Full Text] [Related]
19. Strategies against human papillomavirus infection and cervical cancer.
Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
[TBL] [Abstract][Full Text] [Related]
20. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]